A denylyl cyclase (AC) 1,2 represents one of the principal effector molecules in the β-adrenergic receptor (βAR) signaling pathway, responsible for the conversion of ATP to the second messenger, cAMP. cAMP activates protein kinase A, which phosphorylates several key Ca 2+ -cycling proteins in cardiac myocytes, including phospholamban, ryanodine receptors, troponin I, and L-type Ca 2+ channels (Ca v 1.2). Phosphorylation of these target proteins increases cytoplasmic Ca 2+ , resulting in an increased contractile response of cardiomyocytes. Unlike other components of the βAR signaling pathway, overexpression of AC does not promote cardiac hypertrophy, making it an attractive therapeutic target for heart failure. 3 The mammalian AC gene family contains at least 10 members 4 with several AC isoforms detected in the heart at the transcript level; however, only 2 isoforms (AC V and AC VI ) are found in abundance. 5,6 These 2 isoforms share ≈65% protein sequence identity, and both belong to a group of Ca 2+inhibitable ACs, which can be inhibited by physiological concentrations of Ca 2+ . 5,7 A fundamental difference between the 2 isoforms is that AC V seems to cause detrimental effects in the aging model of cardiomyopathy, whereas overexpression of the AC VI isoform confers beneficial effects in models of cardiac hypertrophy. 8, 9 Subcellular compartmentalization of the βAR signaling proteins allows a variety of biological functions to be regulated at the same time by only a few βAR subtypes. 10, 11 Signaling proteins that are located close to each other can form a working unit, also called a signalosome. Different Rationale: Adenylyl cyclase (AC) represents one of the principal molecules in the β-adrenergic receptor signaling pathway, responsible for the conversion of ATP to the second messenger, cAMP. AC types 5 (AC V ) and 6 (AC VI ) are the 2 main isoforms in the heart. Although highly homologous in sequence, these 2 proteins play different roles during the development of heart failure. Caveolin-3 is a scaffolding protein, integrating many intracellular signaling molecules in specialized areas called caveolae. In cardiomyocytes, caveolin is located predominantly along invaginations of the cell membrane known as t-tubules.
June 7, 2013 subcellular localizations have been shown to occur through a number of scaffolding proteins. Previous studies by Insel et al 12 and Ostrom et al 13 have provided insights into the roles of the caveolin-rich domain in subcellular localization of AC and βARs in cardiac myocytes. In addition, it has been documented that the interactions among different compartments of the βAR signaling are limited by phosphodiesterase (PDE)dependent cAMP degradation. [14] [15] [16] Caveolin is an essential molecule for the formation of caveolae, or membrane invaginations, which are found in most cell types. 17 Caveolae increase the cell surface area, which is important for vesicular trafficking, signal transduction, and macromolecular transport. In the heart, the most abundant isoform of caveolin is caveolin-3, which is associated with long membrane invaginations known as transverse tubules (ttubules) in addition to the surface membrane. 18 Compartmentalization contributes to the complexity of subcellular organization, and alterations in the signaling pathway of a compartment could lead or contribute to cardiac pathology. For example, an increase in β 2 AR reactivity or redistribution of β 2 AR from t-tubules could contribute to cardiac toxicity during the progression of cardiomyopathy. 19 Although the concepts of compartmentalization are well documented, there is still limited understanding of how different compartments are organized and of some of the key effectors in these specialized regions. Specifically, it is not known whether there is similar subcellular compartmentalization of the key effector molecules, AC V and AC VI , in the βAR signaling pathways. Moreover, it has not been established whether different βAR subtypes, namely β 1 AR and β 2 AR, mediate their downstream effects via different isoforms of ACs in the heart. Indeed, new insights into the distinct localization and function of the 2 main AC isoforms will help to shed light on these critical effector molecules during the development and progression of cardiac hypertrophy and failure, possibly providing new therapeutic rationales for these common cardiac conditions.
To accomplish these goals, we took advantage of AC V , AC VI , and AC V /AC VI knockout models to test the central hypothesis that there is subcellular compartmentalization of the 2 main AC isoforms in ventricular myocytes. I Ca,L was recorded as a robust readout of the βAR signaling. The effects of β 1 AR versus β 2 AR signaling via the 2 AC isoforms were tested. Moreover, we provide new mechanistic insights into the pivotal roles of caveolin-3 as a scaffolding protein, which links the specific isoform of AC and PDE, leading to the specialized subcellular organization and forming a separate functional compartment. Finally, we provide evidence that caveolin-3 represents a critical molecule for the compartmentalization of the βAR signaling cascade in cardiac myocytes.
Methods
Detailed Materials and Methods are provided in the Online Data Supplement.
Animals
All animal care and use procedures were approved by the University of California, Davis Institutional Animal Care and Use Committee. Experiments were performed in accordance with National Institutes of Health and institutional guidelines. Genetically targeted mouse models, including AC V knockout (AC V KO) 20 and AC VI knockout (AC VI KO), 7 were used for the studies. The double-knockout (AC V / AC VI KO) mice were generated by crossing the homozygous single KO mice.
Patch-Clamp Recordings
Single left ventricular myocytes were isolated from 10-to 12-weekold animals. All experiments were performed using the conventional whole-cell patch-clamp technique at room temperature. In some experiments, a detubulation technique consisting of an osmotic shock to internalize the t-tubules was used. 21
Western Blot Analyses
Analyses were performed as previously described. 22 Primary antibodies used in the study include anti-β-tubulin (Abcam ab6046, 1:4000 dilution) and anti-Ca v 1.2 (Sigma C1603, 1:200 dilution) antibodies.
Computer Modeling
The Rosetta-Membrane de novo method 23 was used for structure prediction of caveolin. We first generated 10 000 caveolin models of the transmembrane regions of caveolin followed by model clustering as described previously. 23 The center model of the largest cluster was then used for modeling of N and C termini of caveolin using the Rosetta loop modeling method. 24 The AC V and mutated AC V molecule were modeled using the Protein Homolog/analogy Recognition Engine V1.0 (PHYRE) database. 25 Only the peptide segment before the first transmembrane segment was included in the modeling. After both AC V models were created, the peptides were truncated to 20 amino acids to mimic our experiments (amino acids 84-104 of the mouse AC V sequence).
Molecular graphics and analyses were performed using the University of California, San Francisco Chimera package. 26 Dock 6.4 was used for the docking of the peptides. 27, 28 The docking of the peptides used a rigid algorithm (the individual parts of the peptide were kept in the same orientation). The caveolin-3 peptide was treated as a receptor, and the AC V wild-type and mutant peptide was treated as a ligand. The model was run 6 times with a range of grid from 0.1 to 10 Å to confirm the results.
Results

AC VI Isoform Is Critical for the Observed βAR
Enhancement of I Ca,L in Mouse Ventricular Myocytes
We first evaluated the distinct role of AC V and AC VI in βAR stimulation of I Ca,L using the whole-cell patch-clamp technique ( Figure 1 ). Ventricular myocytes were isolated from 4 different groups of animals, including wild type (WT), AC V KO, AC VI KO, and the double KO (AC V /AC VI KO). Application of isoproterenol (ISO) at a concentration of 1 µmol/L significantly increased I Ca,L in WT ventricular myocytes ( Figure 1A) . Similar results were observed in the AC V KO group ( Figure 1A , center). Remarkably, ISO had no effects on I Ca,L in myocytes isolated from AC VI KO ( Figure 1A , bottom) or AC V /AC VI KO myocytes (Online Figure I ). In addition, the basal current was significantly decreased (−1.6±0.4 pA/pF at 0 mV) in AC VI KO myocytes ( Figure 1A , bottom). There was no statistical difference in I Ca,L between AC VI KO and the double-KO myocytes. Summary data for the current density elicited at 0 mV are shown in Figure 1B . I Ca,L was recorded 10 minutes after patch rupture for the current to stabilize. Online Figure IIA shows the time course of the current at baseline and 30 minutes after ISO, demonstrating a relatively stable current in our recording conditions. Indeed, in all our patch-clamp experiments, we have ensured that current recordings were stable with good access before the application of ISO or blockers.
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Taken together, these results suggest that the observed βAR enhancement of I Ca,L occurs mainly via the AC VI isoform. There are 3 main possibilities as to why AC V does not contribute to the observed I Ca,L enhancement. First, the AC V isoform may become degraded in the absence of AC VI . 7 Second, the AC V isoform may not couple directly to βAR. Third, it is possible that the stimulatory effect of the AC V isoform may be compartmentalized and masked by the action of PDE. Indeed, suppression of β 2 AR stimulation by PDE was previously documented. 15 To directly test the last possibility, we investigated the role of AC V and AC VI separately in the β 1 AR and β 2 AR signaling pathways. Figure 2A , top). However, the β 2 AR-dependent enhancement of I Ca,L can be revealed by the application of selective PDE3 and PDE4 blockers, rolipram and cilostamide ( Figure 2B and 2D). Similar to WT ventricular myocytes, application of CGP-20712A also abolished the effect of ISO in the AC V KO (Figure 2A , center). In contrast, additional application of PDE blockers failed to reveal the β 2 AR-dependent increase of I Ca,L ( Figure 2B and 2D). Administration of CGP-20712A in AC VI KO cardiomyocytes did not change the outcome of ISO stimulation, because there was no increase in I Ca,L (Figure 2A , bottom). More important, the addition of PDE blockers in AC VI KO mice revealed the β 2 AR-dependent enhancement of I Ca,L ( Figure 2B and 2D), which was not statistically different from the WT group. Taken together, these results suggest that β 2 AR regulation of I Ca,L may signal mainly via the AC V isoform and is under the strong influence of PDE ( Figure 2C ).
For experiments using PDE blockers, cells were first treated with the blockers for 30 minutes before the addition of ISO. Online Figure IIB shows the time course of the current at baseline, after PDE blockers, and then after ISO in the presence of the blockers.
The significant decrease in the basal I Ca,L in AC VI KO and double-KO myocytes was not associated with significant changes in the expression at the protein or transcript level (Online Figure III) . Moreover, application of PDE3 and PDE4 blockers alone did not alter I Ca,L (Online Figure IIB ), suggesting minimal basal phosphorylation of I Ca,L . Future experiments are required to further explore the mechanisms underlying the decrease in I Ca,L in AC VI KO mice. Nonetheless, the data so far support distinct functional roles of the 2 isoforms of AC in ventricular myocytes. Figure 1 . β-Adrenergic receptor (βAR) enhances I Ca,L in mouse ventricular cardiomyocytes via the activation of adenylyl cyclase type 6 (AC VI ). A, Representative I Ca,L recorded from ventricular myocytes isolated from wild-type (WT, AC V knockout (AC V KO), and AC VI KO. Current traces were elicited using a voltage step of 0 mV for 500 milliseconds from a holding potential of −55 mV at baseline (blue) and after 20 minutes of isoproterenol (ISO; red). The corresponding current-voltage (IV) relations elicited using a family of voltage steps from −40 to 60 mV from a holding potential of −55 mV are shown (right). B, Summary data of I Ca,L density (in pA/pF) from the 3 groups of mice (n=8 for each group; *P<0.05). June 7, 2013
Two Distinct Populations of β 1 ARs in Ventricular Myocytes
To directly examine the downstream signaling pathway of β 1 ARs, we tested the effect of ISO in the presence of 3-(isopropylamino)-1-[(7-methyl-4-indanyl)oxy] butan-2-ol (ICI)-118 551 (a specific β 2 AR blocker). In this condition, ISO increased I Ca,L in the WT myocytes by 145.8±18.8% at 0 mV ( Figure 3A , top). Application of PDE blockers in this condition further potentiated the effect of ISO by 392±63% ( Figure 3B and 3D). A similar enhancement of I Ca,L in AC V KO myocytes was observed by the application of ISO in the presence of ICI-118 551 (108±16.3% increase in the current). However, in contrast to the WT myocytes, PDE blockers failed to further potentiate the effects of ISO in AC V KO myocytes ( Figure 3B and 3D).
As predicted from the results in Figure 1A (bottom), there was no enhancement of I Ca,L by ISO in the presence of ICI-118 551 in AC VI KO myocytes. However, the application of PDE blockers revealed a marked increase of I Ca,L by 814.2±46% ( Figure 3B and 3D). These results suggest that there may exist 2 populations of β 1 ARs: 1 that is associated with AC VI and another that is associated with AC V and is masked by PDE under basal conditions ( Figure 3C ). However, PDE inhibition is known to have effects that are independent of βAR stimulation, which may confound the interpretations. Therefore, additional experiments were performed to further test our hypothesis (Figures 4-6 ).
AC V and AC VI Are the 2 Key Isoforms of AC in Ventricular Myocytes
To test the key isoforms of AC in ventricular myocytes, the effects of ISO on I Ca,L were tested in AC V /AC VI KO myocytes in the absence and presence of PDE blockers. There were no observable effects of ISO in these conditions (Online Figure IA-IC), suggesting that AC V and AC VI represent the 2 main isoforms of AC in ventricular myocytes.
Parallel assessment of cAMP levels in ventricular myocytes isolated from AC V /AC V KO and WT mice was performed as previously described. 29 The same protocol for patch-clamp recordings was used. Specifically, cells were first incubated with PDE inhibitors for 30 minutes before the addition of β-adrenergic agonist plus PDE inhibitors (Online Figure ID) . Results demonstrate a lack of cAMP stimulation in AC V /AC VI KO, consistent with our patch-clamp data.
AC V Isoform Is Compartmentalized Within the t-Tubules Under the Strong Influence of PDE, Whereas AC VI Is Localized Outside the t-Tubules
Our findings thus far support the signaling of β 2 AR mainly via the AC V isoform. Because previous studies have provided evidence for the localization of β 2 AR within the t-tubules, 19 we tested the hypothesis that the AC V is similarly compartmentalized within the t-tubules. After the detubulation procedure, there were no changes in the effects of ISO on I Ca,L in the WT, AC V KO, and AC VI KO myocytes (Online Figure  IVA and IVB compared with Figure 1A ). However, there was a dramatic decrease in the cell capacitance and the amplitude of I Ca,L (Online Figure IVC and IVE). To verify successful detubulation, DI-8-ANEPPS was used to demonstrate the loss of the striation pattern (Online Figure IVD) .
More important, after detubulation, the application of PDE blockers failed to reveal the β 2 AR enhancement of I Ca,L current in WT and AC VI KO cardiomyocytes ( Figure 4A , right column compared with Figure 2B ). In addition, detubulation led to the absence of β 1 AR enhancement of I Ca,L in AC VI KO cardiomyocytes in the presence of PDE blockers ( Figure 4B , bottom compared with Figure 3B ). In contrast, in WT and AC V KO cardiomyocytes, PDE blockers could potentiate the effect of β 1 AR stimulation after detubulation ( Figure 4B , top and center). Taken together, the data support the notion that β 2 ARs signal mainly via the AC V isoform. The AC V isoform is compartmentalized within the t-tubules and is under the strong influence of PDE. Moreover, the AC VI isoform appears to be localized outside of the t-tubules and is under weaker influence of PDE.
Finally, from the detubulation experiments, the fraction of L-type Ca 2+ channels that are localized in the t-tubule versus the sarcolemmal membrane is estimated to be ≈86% (Online Figure IVE) . In addition, we estimated the ratio of Ca 2+ channels in the t-tubules that are regulated by β 1 versus β 2 ARs to be 2.4:1 (Online Figure IVE) .
Caveolin-3 May Anchor and Localize AC V Within t-Tubules
To investigate the mechanisms for the proposed compartmentalization of AC V within the t-tubules, we tested the hypothesis that caveolin-3, a scaffolding protein, may interact with both AC V and PDE, thus localizing AC V within t-tubules under the strong influence of PDE. Indeed, comparison of the amino acid sequence alignment between the N termini of AC V and AC VI isoforms reveals a putative caveolin-binding domain in the AC V but not AC VI isoform ( Figure 5A ). The proposed caveolin-binding domain is found to be conserved in both the mouse and human AC V isoform and contains 4 aromatic amino acids, including phenylalanine, at positions 94, 96, and 98 and tryptophan at position 104 in mouse AC V (Figure 5A ; Online Figure VA) .
To test the hypothesis that the putative caveolin-binding domain may interact with the previously documented caveolin-scaffolding domain in the N terminus of caveolin-3 ( Figure 5B ), we first modeled the caveolin-3 protein using the Rosetta algorithm with a modification for the transmembrane region (Online Figure VB) . Using the docking algorithm, we observed the predicted interactions between the putative caveolin-binding domain and caveolin-scaffolding domain (Online Figure VD and VF) . Changing each of the amino acids phenylalanine 94, 96, and 98 and tryptophan 104 in the putative caveolin-binding domain to alanine (Online Figure  VE) abolished the interactions in the docking procedure.
Inhibitory Peptides Derived From the Putative Caveolin-Binding Domain or Caveolin-Scaffolding Domain Unmask the Stimulatory Effects of ISO on I Ca,L in AC VI KO Mice
We next developed 2 inhibitory peptides (IPs) containing 20 amino acids derived from the N termini of AC V and caveolin-3, which encompass the putative caveolin-binding domain (IP1) and caveolin-scaffolding domain (IP2), respectively. Two control peptides (CPs) were developed by mutating the critical aromatic amino acids (shown in bold in the outlined boxes in Figure 5A and 5B) to alanine.
If caveolin-3 is indeed interacting with AC V and PDE to localize AC V under the strong influence of PDE, we predict that intracellular application of IPs may disrupt the interaction between caveolin-3 and AC V and unmask the stimulatory effects of ISO on I Ca,L in AC VI KO myocytes. In fact, this is what we have observed ( Figure 5C compared with Figure 1A , bottom). In contrast, application of the 2 CPs (CP1 or CP2) Similarly, we also predict a putative caveolin-binding domain in PDE4 isoforms, which seems to be critical for the compartmentalization of AC V isoform ( Figure 6A ). This sequence is found to be conserved in mouse and human PDE4 across all splice variants (>20). An inhibitory peptide was developed using 20-amino acid sequences encompassing the putative caveolin-binding domain of PDE 4b and 4d (IP3; Figure 6A ). A CP was developed by mutating the aromatic amino acid residues to alanine (CP3). Intracellular application of IP3 resulted in the enhancement of ISO on I Ca.L in AC VI KO cardiomyocytes ( Figure 6B compared with Figure 1A , bottom). In contrast, intracellular application of CP3 did not alter the response of AC VI KO cardiomyocytes to ISO ( Figure 6B ).
Interactions Between Caveolin-3 and AC V May Help to Compartmentalize the β 2 AR Signaling
To further test the hypothesis that the interactions between caveolin-3 and AC V may help to compartmentalize the β 2 AR signaling, we tested the effects of the 2 IPs (IP1 or IP2) on the β 2 AR regulation of I Ca,L in WT ventricular myocytes (Online Figure  VIA) . Currents were recorded in control and after ISO stimulation in the presence of a selective β 1 AR blocker (CGP-20712A).
Control experiments are shown on the right using CPs (CP1 or CP2). In contrast to Figure 2A , there was a significant enhancement of I Ca,L in the presence of the IPs (≈22%-30%; Online Figure VIB and VIC). The enhancement of I Ca,L was not observed in AC V KO ventricular myocytes, consistent with data shown using PDE inhibitors ( Figure 2B, center) .
We further test the effects of PDE4 inhibitor alone on the β 2 AR stimulation of WT ventricular myocytes (Online Figure  VID) . PDE4 inhibitor alone was sufficient in relieving the endogenous PDE inhibition on the I Ca,L enhancement, consistent with our data using IP3 ( Figure 6 ).
Immunofluorescence Confocal Microscopic Imaging of Caveolin-3 After Detubulation
To properly interpret the results of the detubulation shown in Figure 4 , we further confirm that there were no significant changes in the localization of caveolin-3 after the detubulation process (see Online Figure VII ; Online Movies). The data further support previous findings that caveolin-3 is localized predominantly in the t-tubules but to a lesser extent on the surface membrane on the surface membrane. 12, 13 Discussion βARs represent one of the most important signaling pathways in the control of heart rates and cardiac contractility. Interest in the βAR pathways stems from their seminal roles in both physiological and pathological conditions. [30] [31] [32] Indeed, the use of βAR blockers has been shown to be one of the most beneficial therapies for the treatment of heart failure, hypertension, and cardiac arrhythmias. 33
Stimulation of L-Type Ca 2+ Channels by β 1 AR and β 2 AR Is Mediated by Different Isoforms of AC
Functional differences between AC V and AC VI isoforms have not been extensively investigated until recently. The lack of isoform-specific antibodies and the relatively small amount of AC available on the membrane presented technical challenges that have recently been overcome with the development of gene-targeted mouse models. Previous studies have provided evidence that AC V disruption increases longevity and protects against stress. 34 In AC VI KO animals, 7 there is a significant decrease in βAR reactivity (≈78% reduction). Double KO animals were previously reported to be nonviable; however, we found that double-KO animals could survive despite high mortality rates within the first 3 weeks after birth. After this period, the mice survive without gross abnormalities. This is similar to the limited survival rate of β 1 AR KO animals. 35 Our data support the divergent roles of the 2 isoforms of AC in the heart. In contrast to previous studies, our data suggest the critical roles of both isoforms. There is a complete lack of enhancement of I Ca,L by βAR stimulation using ISO in AC VI KO and AC V /AC VI double-KO myocytes. This is in contrast to the WT and AC V KO myocytes. To explain this finding, we considered a possibility that the effects of βAR stimulation via AC V isoform may be masked by PDE. Without PDE blockers, the stimulation of I Ca,L from ISO was mediated mostly through β 1 AR activation (Figures 2A and 3A) . Detailed investigation involving the separation of β 1 AR and β 2 AR suggests that the effects of β 2 AR stimulation via the AC V isoform are masked by PDE (as shown in Figure 2 ). Moreover, the enhancement of I Ca,L via the AC V isoform seems to be compartmentalized with both β 1 AR and β 2 AR, whereas the enhancement of I Ca,L via AC VI is mediated mainly through β 1 AR. With the detubulation technique, our data suggest that the enhancement effect of I Ca,L via AC V is compartmentalized within the t-tubule, whereas the effects of AC VI are coupled to L-type Ca 2+ channels, which are localized outside the t-tubules. Indeed, the data are in good agreement with previous findings suggesting that both β 1 AR and β 2 AR are located within the t-tubules, whereas only β 1 AR is present outside the t-tubules. 19 Nonetheless, it remains a possibility that the AC V isoform is present in other cellular domains where it might not be coupled to the L-type Ca 2+ channels directly. Likewise, the AC VI isoform may be localized but does not couple to the L-type Ca 2+ channel in the t-tubules. Future experiments are required to develop antibodies that are isoform specific to directly establish the subcellular localization of the 2 isoforms.
Mechanisms Underlying the Distinct Subcellular Organization and Compartmentalization of AC Isoforms
The different isoforms of AC have similar primary structures containing an N terminus, a 6-transmembrane domain, a C1 portion of the catalytic domain, a second 6-transmembrane domain, and a C2 portion of the catalytic domain. The most striking difference between AC V and AC VI is in the N termini. The N terminus of AC V is much longer than the AC VI terminus, leading us to hypothesize that the specific localization of AC V within the t-tubule may be associated with the N terminus. Because t-tubules are known to contain different lipid contents compared with the outer membrane, we investigated potential differences in the hydrophobicity of the N termini of the 2 isoforms. However, a hydrophobicity plot did not reveal significant differences between the N termini of the AC V and AC VI isoforms.
However, several isoforms of ACs have been shown to be suppressed by the addition of caveolin peptides. 36 Because caveolin is a scaffolding protein localized within the t-tubules in addition to the surface sarcolemma, we first tested the hypothesis that the AC V isoform may possess a caveolinbinding domain. Indeed, caveolin-binding domain sequences vary greatly among different proteins, but all share a similar pattern of aromatic alternating with nonaromatic amino acid residues. 37 We observe a putative caveolin-binding sequence within the N terminus of AC V . This stretch of amino acids is absent in the AC VI isoform ( Figure 5A ). IPs generated from the putative binding sequences are able to disrupt the interaction between caveolin and AC V and to unmask the effects of AC V in AC VI KO animals without PDE blockers. Taken together, the data support our notion that this region within the N terminus of AC V is responsible for the association between AC V and caveolin and thus the specific compartmentalization of AC V within the t-tubules.
The location of PDE4 isoforms along the z-line region was previously reported. 16 Two isoforms of PDE, PDE4b and PDE4d, have been shown to regulate I Ca,L in response to βAR stimulation. 16, 38, 39 We observe a putative caveolin-binding domain within the C termini of the PDE4b and PDE4d isoforms that is highly conserved across species. In fact, the sequence is conserved in >20 different splice variants of PDE4b and PDE4d, suggesting its biological significance. Finally, IPs derived from this putative binding domain unmask the effects of AC V isoform, suggesting that the binding domain is responsible for the interaction between caveolin and PDEs, leading to the compartmentalization of PDE and the AC V isoform within the t-tubules. The schematic representation is presented in Figure 6C .
Potential Clinical Importance and Future Directions
Our findings support the divergent subcellular localization of the 2 main isoforms of AC in ventricular myocytes. The data further suggest that the 2 isoforms represent distinct downstream effector molecules for β 1 AR versus β 2 AR signaling pathways. Because of its specialized location, the effects of the AC V isoform are masked by the action of PDE. Finally, the specific protein-protein interactions with the scaffolding protein, caveolin-3, are responsible for the compartmentalization of the AC V isoform, PDE4b, and PDE4d within the t-tubules of cardiomyocytes.
Our data further provide predictions for the disparate function of the 2 isoforms of AC in the heart. Disruption of AC V , PDE4b, and PDE4d could promote βAR signaling. Indeed, an increase in β 2 AR reactivity has been reported in heart failure, which was explained by the loss of t-tubules in ventricular cardiomyocytes and the redistribution of β 2 ARs. 19 On the basis of our findings, the loss of t-tubules may also be predicted to disrupt the compartmentalization of the AC V -PDE interaction, which may further result in the contribution of β 2 AR to cardiac toxicity. Finally, our findings help explain the domain organization of βARs in the ventricular cardiomyocytes and suggest that the AC V isoform and the PDE4b and PDE4d isoforms work in concert. Because caveolin-3 represents common scaffolding protein essential for the formation of caveolae in different cell types, our findings may be important not only for cardiac physiology and pathophysiology but also for the organization of cellular compartmentalization in other cell types.
